How Secreted-embryo-derived Trypsin Initiates, Maintains and Terminates Ca2+ Signals in Uterine Epithelial Cells

NCT ID: NCT04865367

Last Updated: 2024-07-17

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 81 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2021-11-04
• Study Completion Date: 2023-05-15

Brief Summary

To develop a deeper understanding of endometrial-embryo crosstalk through basic research, uncover therapeutic targets and to improve reproductive outcome.

Detailed Description

Pregnancy is a complex and highly coordinated physiological process that involves implantation of a hatched blastocyst into a decidualizing endometrium. The main purpose of implantation is to ensure that the blastocyst firmly anchors into the decidual stroma, which allows further development by enabling placentation. Although a multitude of cellular events and molecular pathways involved in embryo-uterine crosstalk have been identified in mouse models, a comprehensive understanding of human embryo-uterine interaction is still missing. Our work indicates that endometrial epithelial Ca2+ signalling in response to serine proteases released by human embryos plays an important role in maternal recognition and selection of the conceptus at implantation. Previous studies have demonstrated that trophoblast spheroids can elevate [Ca2+]i in human uterine epithelial cell line (Ishikawa) by activating Ca2+ entry via mechano-sensitive Ca2+ permeable channels leading to the induction of epithelial adhesiveness. However, the mechanism(s) mediating the protease-induced [Ca2+]i transients in human uterine epithelium have not been studied to date. Investigators hypothesise that Na+ entry into the intravillous space via trypsin-activated ENaC will depolarise the cellular membrane and increase [Na+]v sufficiently high to reverse the sodium/calcium exchanger providing means for Ca2+ entry into the intravillous space. Ca2+ diffusion from the microvilli into the bulk cytoplasm will increase [Ca2+]i and, in parallel with SOCE, act as a source for re-filling of the ER. Increased [Ca2+]i will also activate the BK channels leading to repolarisation and termination of Ca2+ entry via the NCX.

By using spent medium from embryos, which will undergo pre-implantation genetic testing, it will become possible to determine, whether the above mentioned mechanisms are influenced by the ploidy status of the embryo.

Conditions

Infertility; Infertility, Female; Aneuploidy

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

DEG n1: euploid medium

culture media derived from euploid embryos

Exposure to culture media

Intervention Type: OTHER

Exposure to culture media

DEG n2: aneuploid medium

culture media derived from aneuploid embryos

Exposure to culture media

Intervention Type: OTHER

Exposure to culture media

DEG n3: medium arrested embryos

culture media derived from arrested embryos

Exposure to culture media

Intervention Type: OTHER

Exposure to culture media

DEG n4: control culture medium

pure culture media without contact to embryos

Exposure to culture media

Intervention Type: OTHER

Exposure to culture media

Interventions

Exposure to culture media

Exposure to culture media

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Couples with primary / secondary infertility who are planned to undergo ICSI treatment with PGT-A
• Age of each partner above 18 years

Exclusion Criteria

• Couples with consanguinity (couple who is 1st or 2nd degree cousins)
• Couples in whom the female partner has a history of:
• Chemotherapy or radiation which impacts the ovarian reserve
• Surgery at the ovaries / adnex region
• Endometriosis
• Couples in whom the male partner has a history of:
• Chemotherapy / Radiation which impacts the semen result
• Surgery at the testicles
• Vasectomy
• Surgery for reversal of vasectomy
• Semen obtained by fine needle aspiration (FNA) or Testicular sperm extraction (TESE)

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 36 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: Yes

Sponsors

University Women's Hospital Tübingen

OTHER

Sponsor Role: collaborator

ART Fertility Clinics LLC

OTHER

Sponsor Role: lead

Responsible Party

Barbara Lawrenz

Scientific Director

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

BARBARA LAWRENZ, PhD

Role: PRINCIPAL_INVESTIGATOR

ART Fertility Clinics LLC

Locations

ART Fertility Clinics LLC

Abu Dhabi, , United Arab Emirates

Countries

United Arab Emirates

References

Wang H, Dey SK. Roadmap to embryo implantation: clues from mouse models. Nat Rev Genet. 2006 Mar;7(3):185-99. doi: 10.1038/nrg1808.

Reference Type: BACKGROUND

PMID: 16485018 (View on PubMed)

Kaneko Y, Day ML, Murphy CR. Integrin beta3 in rat blastocysts and epithelial cells is essential for implantation in vitro: studies with Ishikawa cells and small interfering RNA transfection. Hum Reprod. 2011 Jul;26(7):1665-74. doi: 10.1093/humrep/der128. Epub 2011 Apr 30.

Reference Type: BACKGROUND

PMID: 21531996 (View on PubMed)

Mertzanidou A, Wilton L, Cheng J, Spits C, Vanneste E, Moreau Y, Vermeesch JR, Sermon K. Microarray analysis reveals abnormal chromosomal complements in over 70% of 14 normally developing human embryos. Hum Reprod. 2013 Jan;28(1):256-64. doi: 10.1093/humrep/des362. Epub 2012 Oct 9.

Reference Type: BACKGROUND

PMID: 23054067 (View on PubMed)

Teklenburg G, Salker M, Heijnen C, Macklon NS, Brosens JJ. The molecular basis of recurrent pregnancy loss: impaired natural embryo selection. Mol Hum Reprod. 2010 Dec;16(12):886-95. doi: 10.1093/molehr/gaq079. Epub 2010 Sep 16.

Reference Type: BACKGROUND

PMID: 20847090 (View on PubMed)

Quenby S, Vince G, Farquharson R, Aplin J. Recurrent miscarriage: a defect in nature's quality control? Hum Reprod. 2002 Aug;17(8):1959-63. doi: 10.1093/humrep/17.8.1959.

Reference Type: BACKGROUND

PMID: 12151421 (View on PubMed)

Aplin JD. Embryo implantation: the molecular mechanism remains elusive. Reprod Biomed Online. 2006 Dec;13(6):833-9. doi: 10.1016/s1472-6483(10)61032-2.

Reference Type: BACKGROUND

PMID: 17169205 (View on PubMed)

Zhang S, Lin H, Kong S, Wang S, Wang H, Wang H, Armant DR. Physiological and molecular determinants of embryo implantation. Mol Aspects Med. 2013 Oct;34(5):939-80. doi: 10.1016/j.mam.2012.12.011. Epub 2013 Jan 2.

Reference Type: BACKGROUND

PMID: 23290997 (View on PubMed)

Ruan YC, Guo JH, Liu X, Zhang R, Tsang LL, Dong JD, Chen H, Yu MK, Jiang X, Zhang XH, Fok KL, Chung YW, Huang H, Zhou WL, Chan HC. Activation of the epithelial Na+ channel triggers prostaglandin E(2) release and production required for embryo implantation. Nat Med. 2012 Jul;18(7):1112-7. doi: 10.1038/nm.2771.

Reference Type: BACKGROUND

PMID: 22729284 (View on PubMed)

Rossier BC, Stutts MJ. Activation of the epithelial sodium channel (ENaC) by serine proteases. Annu Rev Physiol. 2009;71:361-79. doi: 10.1146/annurev.physiol.010908.163108.

Reference Type: BACKGROUND

PMID: 18928407 (View on PubMed)

Marunaka Y, Niisato N. Effects of Ca(2+) channel blockers on amiloride-sensitive Na(+) permeable channels and Na(+) transport in fetal rat alveolar type II epithelium. Biochem Pharmacol. 2002 Apr 15;63(8):1547-52. doi: 10.1016/s0006-2952(02)00880-8.

Reference Type: BACKGROUND

PMID: 11996897 (View on PubMed)

Salker MS, Hosseinzadeh Z, Alowayed N, Zeng N, Umbach AT, Webster Z, Singh Y, Brosens JJ, Lang F. LEFTYA Activates the Epithelial Na+ Channel (ENaC) in Endometrial Cells via Serum and Glucocorticoid Inducible Kinase SGK1. Cell Physiol Biochem. 2016;39(4):1295-306. doi: 10.1159/000447834. Epub 2016 Sep 8.

Reference Type: BACKGROUND

PMID: 27606670 (View on PubMed)

Singh Y, Shi X, Zhang S, Umbach AT, Chen H, Salker MS, Lang F. Prolyl hydroxylase 3 (PHD3) expression augments the development of regulatory T cells. Mol Immunol. 2016 Aug;76:7-12. doi: 10.1016/j.molimm.2016.06.003. Epub 2016 Jun 19.

Reference Type: BACKGROUND

PMID: 27331863 (View on PubMed)

Heijnen EM, Eijkemans MJ, De Klerk C, Polinder S, Beckers NG, Klinkert ER, Broekmans FJ, Passchier J, Te Velde ER, Macklon NS, Fauser BC. A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial. Lancet. 2007 Mar 3;369(9563):743-749. doi: 10.1016/S0140-6736(07)60360-2.

Reference Type: BACKGROUND

PMID: 17336650 (View on PubMed)

Brosens JJ, Salker MS, Teklenburg G, Nautiyal J, Salter S, Lucas ES, Steel JH, Christian M, Chan YW, Boomsma CM, Moore JD, Hartshorne GM, Sucurovic S, Mulac-Jericevic B, Heijnen CJ, Quenby S, Koerkamp MJ, Holstege FC, Shmygol A, Macklon NS. Uterine selection of human embryos at implantation. Sci Rep. 2014 Feb 6;4:3894. doi: 10.1038/srep03894.

Reference Type: BACKGROUND

PMID: 24503642 (View on PubMed)

Turco MY, Gardner L, Hughes J, Cindrova-Davies T, Gomez MJ, Farrell L, Hollinshead M, Marsh SGE, Brosens JJ, Critchley HO, Simons BD, Hemberger M, Koo BK, Moffett A, Burton GJ. Long-term, hormone-responsive organoid cultures of human endometrium in a chemically defined medium. Nat Cell Biol. 2017 May;19(5):568-577. doi: 10.1038/ncb3516. Epub 2017 Apr 10.

Reference Type: BACKGROUND

PMID: 28394884 (View on PubMed)

Other Identifiers

2012-ABU-014-BL

Identifier Type: -

Identifier Source: org_study_id